CAN FITE BIOPHAR
CANF AMEX
2.890
-0.230
-7.37%
Closed 16:00 07/23 EDT
Open
3.050
Prev Close
3.120
High
3.101
Low
2.811
Volume
81.61K
Avg Vol (3M)
254.39K
52 Week High
25.95
52 Week Low
2.660
% Turnover
2.46%
Market Cap
9.61M
1D
5D
1M
3M
1Y
5Y
Related
Wells Fargo Multi-Sec IncomeGAMCO Glb Gold Natural Res & IncomePioneer Diversified High IncGLOWPOINT ORDAIR INDUSTRIESNETWORK 1 TECHNOBANCROFTCONS-TOMOKAHEMISPHERX BIOCPI AEROSTRUCTPACIFIC GASGRUPO SIMECUNIV SEC INSTRREEDSTaseko MinesTanzanian Gold CorpCRH MedicalWestern CopperStandard Diversified Inc.Ladenburg Finac
Webull offers CAN FITE BIOPHAR CANF stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.
Company Profile
Can Fite Biofarma Ltd is an Israel-based biopharmaceutical company. The Company develops new treatments for autoimmune diseases and cancer. The Company’s drugs are CF101 for Psoriasis treatment, RA treatment, for the treatment of Keratoconjunctictivitis Sicca, for the treatment of Glaucoma, among others; and CF102 for the treatment of liver diseases. The Company has a research infrastructure including research laboratories and animal house facilities run by the development team. Can Fite Biofarma Ltd signed distribution contracts with a Kwang Dong Pharmaceutical Co. allowing distribution of CF101 for arthritis in Korea and Seikagaku Corp. for distribution in Japan. The Company operates three subsidiaries, Ultratrend Ltd, EyeFite Ltd and OphathaliX Inc.
MORE >Recently
Name
Price
%Change